Healthcare - Biotechnology - NASDAQ - US
$ 1.06
-7.83 %
$ 75.3 M
Market Cap
-2.59
P/E
Price Target
Average
591.82%
Revenue Forecast
Estimate
172.48%
EBIT
Estimate
43.45%
Net Income
Estimate
--1.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ovid Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for OVID of $7.33 , with forecasts ranging from a low of $3 to a high of $11 .
OVID Lowest Price Target
Wall Street Target
3 USD
183.02%
OVID Average Price Target
Wall Street Target
7.33 USD
591.82%
OVID Highest Price Target
Wall Street Target
11 USD
937.74%
REVENUE FORECAST
Revenue Forecast Chart OVID
EBIT FORECAST
EBIT Forecast Chart OVID
NET INCOME FORECAST
Net Income Chart OVID